| Tertile | Crude Analysis | Adjusted for Age and Sex | Adjusted for HAQ, Time-dependent | Adjusted for Age, Sex, and HAQ, Time-dependent |
|---|---|---|---|---|
| All: anti-TNF treatment, time-dependent | 1.10 (0.75–1.61) | 1.21 (1.02–1.43) | 1.17 (0.75–1.83) | 1.38 (0.83–2.27) |
| Tertile 1: anti-TNF treatment, time-dependent | 2.01 (0.88–4.57) | 1.36 (0.89–2.08) | 1.32 (0.40–4.41) | 1.35 (0.39–4.66) |
| Tertile 2: anti-TNF treatment, time-dependent | 1.30 (0.65–2.61) | 1.29 (0.97–1.70) | 1.26 (0.56–2.84) | 1.31 (0.58–2.97) |
| Tertile 3: anti-TNF treatment, time-dependent | 1.21 (0.54–2.70) | 1.14 (0.86–1.52) | 1.34 (0.54–3.34) | 1.45 (0.58–3.64) |
ExRA: extraarticular rheumatoid arthritis; HAQ: Health Assessment Questionnaire; TNF: tumor necrosis factor.